New grad roles at Olema Oncology
Olema Oncology is a clinical-stage biopharmaceutical company developing targeted therapies for breast cancer and other cancers. Its lead program, palazestrant, is an oral estrogen receptor antagonist and degrader in Phase 3 trials for ER-positive, HER2-negative metastatic breast cancer.
- Industry
- Biotech & Pharma, Healthcare & Health Tech
- Company size
- 51–200 employees
- Stage
- Public
- Open roles
- 14
No current roles
Clear a filter to see every role.
Get new Olema Oncology new grad roles by email
Free account. Get new Olema Oncology new grad roles by email or push the minute they post.
